What counts as proof?

An NDC, or National Drug Code, identifies a product in a drug directory; having that code does not establish FDA approval.

An 'FDA registered' medicine maker is recorded with FDA; that record does not give its medicines FDA approval.

Ask to see the approval record for the finished drug. Match the product and the proposed use, rather than relying on a code or badge.

BPC-157, ipamorelin and MOTS-c are names of peptide ingredients sold online. None had an FDA-approved US medicine as of September 2026.

If a service offers one for your health problem, ask what it is meant to do and what studies in people support that use. The ingredient's name alone does not tell you what it treats.

For BPC-157, FDA reports too little safety information to know whether giving it to people would cause harm.

FDA flags claims that made-to-order drugs are clinically proven to give the same result as approved products.

Ask which findings come from people, and whether the studied product matches the proposed one. Ask what has not been established.

FDA keeps a list of drug ingredients permitted for compounding under certain rules. Being on that list does not give a finished medicine FDA approval.

An FDA advisory committee is a group offering advice to FDA. A committee vote alone cannot add an ingredient to the list; FDA must complete a formal rule change.

In July 2026, the committee met to discuss adding seven peptide ingredients to that list.

FDA had issued no official record of the July meeting's votes as of September 2026.

If an offer says a committee vote now allows your medicine, ask for the current ingredient rule that permits it. Keep checking the finished medicine's approval separately.